Suppr超能文献

晶体肾病:晶体诱导肾损伤的机制。

Crystal nephropathies: mechanisms of crystal-induced kidney injury.

机构信息

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU Munich, Ziemssenstrasse 1, 80336 München, Germany.

出版信息

Nat Rev Nephrol. 2017 Apr;13(4):226-240. doi: 10.1038/nrneph.2017.10. Epub 2017 Feb 20.

Abstract

Crystals can trigger a wide range of kidney injuries that can lead to acute kidney injury, chronic kidney disease, renal colic or nephrocalcinosis, depending on the localization and dynamics of crystal deposition. Studies of the biology of crystal handling by the kidney have shown that the formation of different crystals and other microparticles and the associated mechanisms of renal damage share molecular mechanisms, such as stimulation of the NLRP3 inflammasome or direct cytotoxicity through activation of the necroptosis signalling pathway. By contrast, crystal granuloma formation is limited to chronic crystallopathies that lead to chronic kidney disease and renal fibrosis. Here, we discuss current understanding of the pathomechanisms underlying the different types of crystal-induced kidney injury and propose a classification of crystal nephropathies based on the localization of crystal deposits in the renal vasculature (type 1), the nephron (type 2), or the draining urinary tract (type 3). Further exploration of the molecular mechanisms of crystal-induced kidney injury and renal remodelling might aid the development of innovative cures for these diseases.

摘要

晶体可引发广泛的肾脏损伤,从而导致急性肾损伤、慢性肾脏病、肾绞痛或肾钙质沉着症,具体取决于晶体沉积的定位和动态变化。对肾脏处理晶体生物学的研究表明,不同晶体和其他微粒的形成以及相关的肾损伤机制具有共同的分子机制,例如通过激活 NLRP3 炎性小体或通过激活坏死性凋亡信号通路直接引起细胞毒性作用。相比之下,晶体肉芽肿的形成仅限于导致慢性肾脏病和肾纤维化的慢性结晶性疾病。在这里,我们讨论了不同类型晶体诱导的肾脏损伤的发病机制的现有认识,并根据晶体在肾脏血管(1 型)、肾单位(2 型)或引流尿路(3 型)中的沉积位置,提出了一种晶体肾病的分类方法。进一步探索晶体诱导的肾脏损伤和肾脏重塑的分子机制可能有助于为这些疾病开发创新的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验